Apino Pharma Co., Ltd.

Apino Pharma focuses on phamraceutical industry especially APIs and Key Intermediates as well as full service from R&D stage to commercial stage with the concept of “Added Value, Profession, Innovation”. We strictly follow the principle “Quality First” by supplying most reliable quality, professional service and reasonable price for the customers.

Apino supply below featured products and professional service:
1.APIs (Mainly new generic APIs and Biosimilar products-Peptides, Anti-cancer mabs, Insulin…etc.)
3.Finished products
4.Custom Synthesis Service

Insulin Glargine (DMF available) manufacturered by US FDA approved factory CasNo.: 160337-95-1

Insulin glargine (CAS 160337-95-1) is a long-acting basal insulin analogue, helping control the blood sugar level of those with type 1 and type 2 diabetes mellitus. It is an analogue of human insulin made by replacing the asparagine residue at position A21 of the A-chain with glycine and adding two arginines to the C-terminus (positions B31 and 32) of the B-chain. Right now, insulin glargine (CAS 160337-95-1) API is commercially available . We are working on its international registration, such as DMF/ CEP/ J-DMF and so on. If you need insulin glargine API with DMF USP grade (CAS 160337-95-1), please kindly contact us via following contact information., Insulin, Insulin glargine

Cetuximab 100mg/20ml Injection(Bulk solution can be supplied commercially as well)

Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. Both the finished product of Cetuximab and bulk solution can be supplied commercially!, Cetuximab, Anti cancer

Read More
Get Quote
Send Inquiry by feedback form learn more about product detail, price, etc
*Your email address will not be published. Required fields are marked.